'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.
about
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis BBiology of hepatocellular carcinomaGlycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumourAutoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma.Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma.A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma.Recent developments in the first detection of hepatocellular carcinomaPrimary liver tumors.[Hepatocellular carcinoma in rural Burkina Faso Africa: contribution of ultrasound, about 58 cases].Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.Mass spectrometry-based proteomics: current status and potential use in clinical chemistry.Future perspectives for hepatocellular carcinoma.Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinomaStructures of disease-specific serum alpha-fetoprotein isoforms.Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinomaAntibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis.MicroRNA-421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer.High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver
P2860
Q24248748-0C106D9B-84C7-4909-895E-C4DA66F6F509Q28266656-0F497596-0D8C-4CB1-9F6E-270B7EF31D5BQ30822385-67B3D035-6F34-417E-B1B4-46D3D1A6D719Q33493776-8C2AE312-BECB-4BEA-93AC-6F8FE184B792Q33670353-ECB7F2E9-7B5B-4F5A-AD61-1560955BBEF8Q33730001-96E55E98-9340-40AD-8B91-3D32F62C6CDAQ33739952-51FC59C8-0391-4779-A2E8-F7866C6E03F1Q33895863-E73398F7-3750-4FDE-9F87-34F6E58E237DQ34055894-DC3D2D56-7636-466B-A9EB-755AFD919C15Q34110964-17F36DFC-BD40-4DDF-A41E-E2A61F194264Q35211891-7B6717D1-73CA-436C-9458-1AF9F5EBCD97Q35343013-B6DEBA5E-BDDC-4FE6-9ADE-5930736CB735Q35621902-C3971AED-AB60-4105-A11F-83896902CEBFQ36063224-22B6F50B-1919-4DCA-A9C2-BA85323763F8Q36640435-A885C4D8-BB9F-462C-995F-9A25516DC0D8Q36692019-CFFCA70A-05B1-40A1-9D94-0415E6BCB211Q37187763-2E9EB27D-A0EB-476B-88C7-879A24FC99B9Q37252915-0CF3FDF4-0676-4D83-BDD5-73C05A9CCFBBQ42555303-E22317B9-E699-4B6F-8C29-7D9BE3E3D27DQ53661249-0515BC93-2F79-4C0C-86EC-DC6E3593BDF9Q57782512-A81E4CF2-0A6E-48DA-AB63-B5EFC23299D3
P2860
'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@en
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@nl
type
label
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@en
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@nl
prefLabel
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@en
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@nl
P2093
P2860
P356
P1476
'Hepatoma-specific' alphafetop ...... ts with chronic liver disease.
@en
P2093
Johnson PJ
P2860
P2888
P304
P356
10.1038/BJC.1997.39
P407
P577
1997-01-01T00:00:00Z